Antigen presentation by tolerogenic dendritic cells: the MOG35-55 -mannan conjugate paradigm. A potential therapeutic vaccine for Multiple Sclerosis

Full text for this resource is not available from the Research Repository.

Rodi, M, de Lastic, AL, Antonopoulou, S, Kylintireas, C, Apostolopoulos, Vasso ORCID logoORCID: https://orcid.org/0000-0001-6788-2771, Matsoukas, J and Mouzaki, A (2019) Antigen presentation by tolerogenic dendritic cells: the MOG35-55 -mannan conjugate paradigm. A potential therapeutic vaccine for Multiple Sclerosis. Review of Clinical Pharmacology and Pharmacokinetics, International Edition, 33 (3). pp. 92-93. ISSN 1011-6583

Item type Article
URI https://vu-9.eprints-hosting.org/id/eprint/41133
Subjects Historical > FOR Classification > 1107 Immunology
Current > Division/Research > College of Health and Biomedicine
Keywords autoimmune disease; central nervous system; immunological tolerance; T cell tolerance
Citations in Scopus 0 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login